Rebecca Byam - Aug 30, 2022 Form 4 Insider Report for HCW Biologics Inc. (HCWB)

Role
Chief Financial Officer
Signature
/s/ Nicole Valdivieso, as Attorney-in-Fact for Rebecca A. Byam
Stock symbol
HCWB
Transactions as of
Aug 30, 2022
Transactions value $
$43,913
Form type
4
Date filed
9/1/2022, 04:01 PM
Previous filing
Aug 30, 2022
Next filing
Sep 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCWB Common Stock Purchase $18.3K +7.2K +2.71% $2.55 273K Aug 30, 2022 Direct F1
transaction HCWB Common Stock Purchase $25.6K +10K +3.66% $2.56 283K Aug 31, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The range of prices for the shares of Common Stock is from $2.53 to $2.56. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
F2 The range of prices for the shares of Common Stock is from $2.56 to $2.58. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.